相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oritavancin Activity against Staphylococcus aureus Causing Invasive Infections in U. S. and European Hospitals: a 5-Year International Surveillance Program
Rodrigo E. Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Cell permeable vanX inhibitors as vancomycin re-sensitizing agents
Ramaiah Muthyala et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
New Insights into Glycopeptide Antibiotic Binding to Cell Wall Precursors using SPR and NMR Spectroscopy
Juan Trevino et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Large-Scale Metagenomic-Based Study of Antibiotic Resistance in the Environment
Joseph Nesme et al.
CURRENT BIOLOGY (2014)
The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA
Benjamin P. Howden et al.
INFECTION GENETICS AND EVOLUTION (2014)
Multicomponent antibiotic substances produced by fermentation: Implications for regulatory authorities, critically ill patients and generics
Adrian J. Brink et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study
J. A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Glycopeptide antibiotic biosynthesis
Grace Yim et al.
JOURNAL OF ANTIBIOTICS (2014)
Human Cathelicidin LL-37 Resistance and Increased Daptomycin MIC in Methicillin-Resistant Staphylococcus aureus Strain USA600 (ST45) Are Associated with Increased Mortality in a Hospital Setting
George Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
Flavia Rossi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin
Mu Cheng et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Comparison of Six Generic Vancomycin Products for Treatment of Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis in Rabbits
P. Tattevin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Comprehensive Identification of Mutations Responsible for Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA)-to-VISA Conversion in Laboratory-Generated VISA Strains Derived from hVISA Clinical Strain Mu3
Miki Matsuo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Locations of the Hydrophobic Side Chains of Lipoglycopeptides Bound to the Peptidoglycan of Staphylococcus aureus
Sung Joon Kim et al.
BIOCHEMISTRY (2013)
Design, Synthesis, and Antibacterial Activity of Demethylvancomycin Analogues against Drug-Resistant Bacteria
Jun Chang et al.
CHEMMEDCHEM (2013)
Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?
Sebastiaan J. van Hal et al.
CLINICAL INFECTIOUS DISEASES (2013)
Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011)
Ronald N. Jones et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)
Ronald N. Jones et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Developing new antibacterials through natural product research
Herbert A. Kirst
EXPERT OPINION ON DRUG DISCOVERY (2013)
Community-associated MRSA: What makes them special?
Michael Otto
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Antibiotics in the clinical pipeline in 2013
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2013)
Probing the Role of the Vancomycin E-Ring Aryl Chloride: Selective Divergent Synthesis and Evaluation of Alternatively Substituted E-Ring Analogues
Joseph R. Pinchman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
First case of infection with vancomycin-resistant Staphylococcus aureus in Europe
Jose Melo-Cristino et al.
LANCET (2013)
Platforms for antibiotic discovery
Kim Lewis
NATURE REVIEWS DRUG DISCOVERY (2013)
Platelet-Type von Willebrand Disease: New Insights into the Molecular Pathophysiology of a Unique Platelet Defect
Maha Othman et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2013)
Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection Model
Carlos A. Rodriguez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives
Si-Ji Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Current State of Clostridium difficile Treatment Options
Anilrudh A. Venugopal et al.
CLINICAL INFECTIOUS DISEASES (2012)
The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
S. J. van Hal et al.
CLINICAL INFECTIOUS DISEASES (2012)
Screening Strategies to Identify New Antibiotics
Mark S. Butler et al.
CURRENT DRUG TARGETS (2012)
Overcoming the challenges to developing new antibiotics
David M. Shlaes et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
In vitro activity of telavancin and occurrence of vancomycin heteroresistance in isolates from patients enrolled in phase 3 clinical trials of hospital-acquired pneumonia
Kevin M. Krause et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study
Jun Yamakawa et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Site-Selective Bromination of Vancomycin
Tejas P. Pathak et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Silver(I)-Promoted Conversion of Thioamides to Amidines: Divergent Synthesis of a Key Series of Vancomycin Aglycon Residue 4 Amidines That Clarify Binding Behavior to Model Ligands
Akinori Okano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Total Synthesis of [Ψ[C(=S)NH]Tpg4]Vancomycin Aglycon, [Ψ[C(=NH)NH]Tpg4]Vancomycin Aglycon, and Related Key Compounds: Reengineering Vancomycin for Dual D-Ala-D-Ala and D-Ala-D-Lac Binding
Jian Xie et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Antibiotic resistance is ancient: implications for drug discovery
Gerard D. Wright et al.
TRENDS IN MICROBIOLOGY (2012)
Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300
Susana Gardete et al.
PLOS PATHOGENS (2012)
Structure of ristocetin A in complex with a bacterial cell-wall mimetic. Corrigendum (vol 65, pg 832, 2009)
Virginie Nahoum et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
Sebastiaan J. van Hal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Mutation of RNA Polymerase β Subunit (rpoB) Promotes hVISA-to-VISA Phenotypic Conversion of Strain Mu3
Miki Matsuo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA
Rasmus V. Rasmussen et al.
FUTURE MICROBIOLOGY (2011)
Antibiotics in the clinical pipeline in 2011
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2011)
Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns
Sebastiaan J. van Hal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
Natasha E. Holmes et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Synthesis and Stereochemical Determination of Complestatin A and B (Neuroprotectin A and B)
Steven P. Breazzano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
A Redesigned Vancomycin Engineered for Dual D-Ala-D-Ala and D-Ala-D-Lac Binding Exhibits Potent Antimicrobial Activity Against Vancomycin-Resistant Bacteria
Jian Xie et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Antibiotic resistance is ancient
Vanessa M. D'Costa et al.
NATURE (2011)
A guiding hand for antibiotics
Dan Jones
NATURE REVIEWS DRUG DISCOVERY (2011)
Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator
Omar Vesga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
Adam Belley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Benjamin P. Howden et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
New Lipoglycopeptides A Comparative Review of Dalbavancin, Oritavancin and Telavancin
George G. Zhanel et al.
DRUGS (2010)
Oritavancin: a novel lipoglycopeptide active against Gram-positive pathogens including multiresistant strains
Emilio Bouza et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia
Michael A. Pfaller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Synthesis and Evaluation of Selected Key Methyl Ether Derivatives of Vancomycin Aglycon
Christine M. Crane et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Discovery of a Novel Series of Semisynthetic Vancomycin Derivatives Effective against Vancomycin-Resistant Bacteria
Yuki Nakama et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Michael T. Guskey et al.
PHARMACOTHERAPY (2010)
Structure of ristocetin A in complex with a bacterial cell-wall mimetic
Virginie Nahoum et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
Ultrastructural Effects of Oritavancin on Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus
Adam Belley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
Longzhu Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies
Klaudia Kosowska-Shick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II
Christopher S. Lunde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus by Imipenem
Yuki Katayama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin
Francis F. Arhin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
Adina C. Musta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Diazo Transfer-Click Reaction Route to New, Lipophilic Teicoplanin and Ristocetin Aglycon Derivatives with High Antibacterial and Anti-influenza Virus Activity: An Aggregation and Receptor Binding Study
Gabor Pinter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
Gary J. Patti et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Telavancin
G. Ralph Corey et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Heteroresistance: a concern of increasing clinical significance?
M. E. Falagas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Adis drug profile - Dalbavancin
Vanessa R. Anderson et al.
DRUGS (2008)
Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus
Ian M. Gould
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions
Christopher Weidenmaier et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance
Hui-Min Neoh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
Eric Sauvage et al.
FEMS MICROBIOLOGY REVIEWS (2008)
Withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health
Ian Phillips
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing
Michael M. Mwangi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Unstable vancomycin heteroresistance is common among clinical isolates of methiciliin-resistant Staphylococcus aureus
N Plipat et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Origin, structure, and activity in vitro and in vivo of dalbavancin
A Malabarba et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus
DL Higgins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Glycopeptide and lipoglycopeptide antibiotics
D Kahne et al.
CHEMICAL REVIEWS (2005)
Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424)
MR Leadbetter et al.
JOURNAL OF ANTIBIOTICS (2004)
Total synthesis of the ristocetin aglycon
BM Crowley et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data
I Phillips et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Semi-synthetic glycopeptide antibacterials
JK Judice et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
The vanG glycopeptide resistance operon from Enterococcus faecalis revisited
F Depardieu et al.
MOLECULAR MICROBIOLOGY (2003)
Total synthesis of anti-HIV agent chloropeptin I
HB Deng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose
F Pea et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001
SK Fridkin et al.
CLINICAL INFECTIOUS DISEASES (2003)
A clonal lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant enterococci isolated in New Zealand
JM Manson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus
K Sieradzki et al.
JOURNAL OF BACTERIOLOGY (2003)
Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus
L Cui et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Assembling the glycopeptide antibiotic scaffold:: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL 15009
J Pootoolal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Total synthesis of teicoplanin aglycon
DA Evans et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Glycopeptide derivatives
A Malabarba et al.
CURRENT MEDICINAL CHEMISTRY (2001)
Neuroprotectins A and B, bicyclohexapeptides protecting chick telencephalic neuronal cells from excitotoxicity - I. Fermentation, isolation, physico-chemical properties and biological activity
H Kobayashi et al.
JOURNAL OF ANTIBIOTICS (2001)
Neuroprotectins A and B, bicyclohexapeptides protecting chick telencephalic neurons from excitotoxicity - II. Structure determination
H Kobayashi et al.
JOURNAL OF ANTIBIOTICS (2001)
Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals
Y Ike et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
M Wootton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
First and second generation total synthesis of the teicoplanin aglycon
DL Boger et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis
SJ McKessar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Thermal atropisomerism of teicoplanin aglycon derivatives:: Preparation of the P,P,P and M,P,P atropisomers of the teicoplanin aglycon via selective equilibration of the DE ring system
DL Boger et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes
A Peschel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Total synthesis of the teicoplanin aglycon
DL Boger et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Drug therapy: Vancomycin-resistant enterococcal infections.
BE Murray
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates
S Boyle-Vavra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
